Gene · 7307
Papers3,382
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 3,382
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Neoantigens: promising targets for cancer therapy. | Signal Transduct Target Ther | 2023 | 36604431 | PubTator, text mining | PubMed |
| Long-term treatment with pacritinib on a compassionate use basis in patients with advanced myelofibrosis. | Haematologica | 2023 | 36601980 | PubTator, text mining | PubMed |
| Determinants of survival and retrospective comparisons of 183 clinical trial patients with myelofibrosis treated with momelotinib, ruxolitinib, fedratinib or BMS- 911543 JAK2 inhibitor. | Blood Cancer J | 2023 | 36599841 | PubTator, text mining | PubMed |
| Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AML. | Blood Cancer J | 2023 | 36599822 | PubTator, text mining | PubMed |
| Clinical and molecular spectrum and prognostic outcomes of U2AF1 mutant clonal hematopoiesis- a prospective mayo clinic cohort study. | Leuk Res | 2023 | 36586169 | PubTator, text mining | PubMed |
| Gene-environment interactions and their impact on human health. | Genes Immun | 2023 | 36585519 | PubTator, text mining | PubMed |
| International Consensus Classification of myeloid and lymphoid neoplasms: myeloproliferative neoplasms. | Virchows Arch | 2023 | 36580136 | PubTator, text mining | PubMed |
| Effects of nandrolone decanoate on telomere length and clinical outcome in patients with telomeropathies: a prospective trial. | Haematologica | 2023 | 36579443 | PubTator, text mining | PubMed |
| Clonal dynamics using droplet digital polymerase chain reaction in peripheral blood predicts treatment responses in myelodysplastic syndrome. | Haematologica | 2023 | 36579442 | PubTator, text mining | PubMed |
| Inhibiting androgen receptor splice variants with cysteine-selective irreversible covalent inhibitors to treat prostate cancer. | Proc Natl Acad Sci U S A | 2023 | 36577061 | PubTator, text mining | PubMed |
| How I Manage Transplant Ineligible Patients with Myelodysplastic Neoplasms. | Clin Hematol Int | 2023 | 36574201 | PubTator, text mining | PubMed |
| Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children. | Leukemia | 2023 | 36572751 | PubTator, text mining | PubMed |
| Biology and therapeutic targeting of molecular mechanisms in MPNs. | Blood | 2023 | 36534936 | PubTator, text mining | PubMed |
| Roles of RNA-binding proteins in neurological disorders, COVID-19, and cancer. | Hum Cell | 2023 | 36528839 | PubTator, text mining | PubMed |
| Predictors of response to venetoclax plus hypomethylating agent therapy and survival in blastphase myeloproliferative neoplasm. | Haematologica | 2023 | 36519330 | PubTator, text mining | PubMed |
| RUNX1 isoform disequilibrium promotes the development of trisomy 21-associated myeloid leukemia. | Blood | 2023 | 36493345 | PubTator, text mining | PubMed |
| Long noncoding RNA MEG3 inhibits oral squamous cell carcinoma progression via GATA3. | FEBS Open Bio | 2023 | 36468944 | PubTator, text mining | PubMed |
| Mutations in spliceosome genes in myelodysplastic neoplasms and their association to ring sideroblasts. | Leukemia | 2023 | 36463343 | PubTator, text mining | PubMed |
| Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia. | Blood Adv | 2023 | 36441905 | PubTator, text mining | PubMed |
| A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study. | Lancet Haematol | 2023 | 36436542 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7307/papers?page=33